The relationship of three common definitions of the metabolic syndrome with sub-clinical carotid atherosclerosis

Atherosclerosis

Volumn 198, Issue 1, 2008, Pages 228-236

  Paras, Erica ^a   Mancini, G B John ^b   Lear, Scott A ^a,b  

^a SIMON FRASER UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Carotid atherosclerosis; IDF; Metabolic syndrome; NCEP; WHO

Indexed keywords

ADULT; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; COHORT ANALYSIS; DEMOGRAPHY; DISEASE ASSOCIATION; ECHOGRAPHY; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; RISK FACTOR; SMOKING; WORLD HEALTH ORGANIZATION;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BRITISH COLUMBIA; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CONSENSUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INDIANS, NORTH AMERICAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; REGRESSION ANALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; WORLD HEALTH ORGANIZATION;

EID: 40949133828     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.09.007     Document Type: Article

References (34)

1. Borgman M., and McErlean E. What is the metabolic syndrome? Prediabetes and cardiovascular risk. J Cardiovasc Nurs 21 (2006) 285-290
2. Brien S.E., and Katzmarzyk P.T. Physical activity and the metabolic syndrome in Canada. Appl Physiol Nutr Metab 31 (2006) 40-47
3. Pollex R.L., Al-Shali K.Z., House A.A., et al. Relationship of the metabolic syndrome to carotid ultrasound traits. Cardiovasc Ultrasound 4 (2006) 28
4. Fan A.Z. Metabolic syndrome and progression of atherosclerosis among middle-aged US adults. J Atheroscler Thromb 13 (2006) 46-54
5. Tenenbaum A., Motro M., Schwammenthal E., and Fisman E.Z. Macrovascular complications of metabolic syndrome: an early intervention is imperative. Int J Cardiol 97 (2004) 167-172
6. Wallenfeldt K., Hulthe J., and Fagerberg B. The metabolic syndrome in middle-aged men according to different definitions and related changes in carotid artery intima-media thickness (IMT) during 3 years of follow-up. J Intern Med 258 (2005) 28-37
7. Saely C.H., Koch L., Schmid F., et al. Adult Treatment Panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography. Diabetes Care 29 (2006) 901-907
8. Scuteri A., Najjar S.S., Morrell C.H., and Lakatta E.G. The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study. Diabetes Care 28 (2005) 882-887
9. Scuteri A., Najjar S.S., Muller D.C., et al. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol 43 (2004) 1388-1395
10. Despres J.P., and Lemieux I. Abdominal obesity and metabolic syndrome. Nature 444 (2006) 881-887
11. Wassink A.M., Olijhoek J.K., and Visseren F.L. The metabolic syndrome: metabolic changes with vascular consequences. Eur J Clin Invest 37 (2007) 8-17
12. Feinstein S.B. Contrast ultrasound imaging of the carotid artery vasa vasorum and atherosclerotic lesion neovascularization. J Am Coll Cardiol 48 (2006) 236-243
13. Jashnani K.D., Kulkarni R.R., and Deshpande J.R. Role of carotid intima-media thickness in assessment of atherosclerosis: an autopsy study. Indian Heart J 57 (2005) 319-323
14. Kablak-Ziembicka A., Przewlocki T., Kostkiewicz M., et al. Relationship between carotid intima-media thickness, atherosclerosis risk factors and angiography findings in patients with coronary artery disease. Przegl Lek 60 (2003) 612-616
15. Kablak-Ziembicka A., Tracz W., Przewlocki T., et al. Association of increased carotid intima-media thickness with the extent of coronary artery disease. Heart 90 (2004) 1286-1290
16. Anand S.S., Yusuf S., Vuksan V., et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 356 (2000) 279-284
17. Lu B., Yang Y., Song X., et al. An evaluation of the International Diabetes Federation definition of metabolic syndrome in Chinese patients older than 30 years and diagnosed with type 2 diabetes mellitus. Metabolism 55 (2006) 1088-1096
18. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
19. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
20. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome; 2005.
21. Sone H., Tanaka S., Ishibashi S., et al. The new worldwide definition of metabolic syndrome is not a better diagnostic predictor of cardiovascular disease in Japanese diabetic patients than the existing definitions: additional analysis from the Japan Diabetes Complications Study. Diabetes Care 29 (2006) 145-147
22. Sone H., Mizuno S., Fujii H., et al. Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in asian diabetic patients? Analysis from the Japan Diabetes Complications Study. Diabetes Care 28 (2005) 1463-1471
23. Deepa M., Farooq S., Datta M., Deepa R., and Mohan V. Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev 23 (2007) 127-134
24. Lorenzo C., Williams K., Hunt K.J., and Haffner S.M. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 30 (2007) 8-13
25. Kahn R., Buse J., Ferrannini E., et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28 (2005) 2289-2304
26. Lear S.A., Birmingham C.L., Chockalingam A., and Humphries K.H. Study design of the multicultural community health assessment trial (M-CHAT)-a comparison of body fat distribution in four distinct populations. Ethn Dis 16 (2006) 96-100
27. European Multicentre Orlistat Study Group, Sjostrom L., Rissanen A., Andersen T., et al. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet 352 (1998) 167-172
28. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
29. Aminbakhsh A., Frohlich J., and Mancini G.B. Detection of early atherosclerosis with B mode carotid ultrasonography: assessment of a new quantitative approach. Clin Invest Med 22 (1999) 265-274
30. Chan S.Y., Mancini G.B., Kuramoto L., et al. The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. J Am Coll Cardiol 42 (2003) 1037-1043
31. Zureik M., Touboul P.J., Bonithon-Kopp C., et al. Differential association of common carotid intima-media thickness and carotid atherosclerotic lesions with parental history of premature death from coronary heart disease: the EVA study. Arterioscler Thromb Vasc Biol 19 (1999) 366-371
32. Anand S.S., Yi Q., Gerstein H., et al. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation 108 (2003) 420-425
33. Lakka H.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
34. Vasan R.S., Sullivan L.M., Wilson P.W., et al. Relative importance of borderline and elevated levels of coronary heart disease risk factors. Ann Intern Med 142 (2005) 393-402